{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:02:41Z","timestamp":1791291761711,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.2146\/ajhp090229","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T21:46:35Z","timestamp":1274219195000},"page":"895-900","source":"Crossref","is-referenced-by-count":35,"title":["Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature"],"prefix":"10.1093","volume":"67","author":[{"given":"Lisa","family":"Charneski","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather Brennan","family":"Congdon","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Maryland, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041104263044400_b1-0670895","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104263044400_b2-0670895","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","volume":"2007","author":"Ataga","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key\n\t\t\t\t2019041104263044400_b3-0670895","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"issue":"suppl","key":"key\n\t\t\t\t2019041104263044400_b4-0670895","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edition","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041104263044400_b5-0670895","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200006223422512","article-title":"Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies","volume":"342","author":"Hebbel","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104263044400_b6-0670895","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.amjmed.2003.07.011","article-title":"Hypercoagulability in sickle cell disease: a curious paradox","volume":"115","author":"Ataga","year":"2003","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041104263044400_b7-0670895","first-page":"440","article-title":"Hemostatic alterations accompany sickle cell pain crises","volume":"88","author":"Alkjaersig","year":"1976","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t2019041104263044400_b8-0670895","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000207105","article-title":"Therapeutic effect of aspirin in sickle cell anaemia","volume":"66","author":"Osamo","year":"1981","journal-title":"Acta Haematol"},{"key":"key\n\t\t\t\t2019041104263044400_b9-0670895","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041104263044400_b10-0670895","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000206360","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"key":"key\n\t\t\t\t2019041104263044400_b11-0670895","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1650055","article-title":"Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises","volume":"43","author":"Chaplin","year":"1980","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t2019041104263044400_b12-0670895","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0038-1661088","article-title":"A double-blind trial of ticlopidine in sickle cell disease","volume":"51","author":"Semple","year":"1984","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t2019041104263044400_b13-0670895","first-page":"574","article-title":"Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises","volume":"66","author":"Chaplin","year":"1989","journal-title":"East Afr Med J"},{"key":"key\n\t\t\t\t2019041104263044400_b14-0670895","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial","volume":"98","author":"Qari","year":"2007","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t2019041104263044400_b15-0670895","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM196307252690403","article-title":"Long-term anticoagulation in sickle-cell disease: a clinical study","volume":"269","author":"Salvaggio","year":"1963","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104263044400_b16-0670895","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.1175","article-title":"Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study","volume":"68","author":"Schnog","year":"2001","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041104263044400_b17-0670895","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0902-4441.2003.00209.x","article-title":"Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report","volume":"72","author":"Ahmed","year":"2004","journal-title":"Eur J Haematol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/11\/895\/28344131\/ajhp0895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:20:09Z","timestamp":1559118009000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/11\/895\/5130758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp090229","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,6,1]]},"published":{"date-parts":[[2010,6,1]]}}}